Licensing opportunity
Researchers at Strathclyde University, Scotland, have developed a coronary stent that incorporates a sensor, which with further development, will be capable of continuously monitoring the occurrence of restenosis, or potential blocking of the stent, and transmitting this data to a device outside the body.
The stent has been tested in in vitro models of restenosis and is now ready to be tested in animal models
Key benefits include the ability to carry out continuous in situ monitoring of restenosis, and the fact that the system is self-reporting and non-invasive, with no catheterisation required.
The researchers say it should allow for earlier treatment of the condition.
Contact is welcomed from organisations interested in developing, licensing or exploiting this technology. Strathclyde University is securing patent protection for the technology.
For more information, visit the project’s page at: http://www.university-technology.com/details/intelligent-cardiovascular-stent
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening. 
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.
